Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821184 · ClinicalTrials.gov registry record · Phase 3
Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder
A Phase 3 study, sponsored by Lahey Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
NCT00821184 is a Phase 3 study that was terminated before completion, run by Lahey Clinic. The registered enrollment target is 12 participants.
The verdict
NCT00821184, a Phase 3 study, was terminated before completion, sponsored by Lahey Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will help determine if behavior modification performed in conjunction with oral Vesicare anticholinergic therapy is more effective for treating overactive bladder symptoms than oral Vesicare anticholinergic therapy alone.
Interventions
- DRUG Vesicare (solifenacin)
- BEHAVIORAL Vesicare (solifenacin) plus behavioral modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00821184
The ClinicalTrials.gov registry entry for NCT00821184 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vesicare (solifenacin) is the first listed.
NCT00821184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00821184 about?
NCT00821184 is a clinical study titled "Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder". This study will help determine if behavior modification performed in conjunction with oral Vesicare anticholinergic therapy is more effective for treating overactive bladder symptoms than oral Vesicare anticholinergic therapy alone.
What is the current status of trial NCT00821184?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2006-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00821184?
The interventions under investigation include: Vesicare (solifenacin) (DRUG), Vesicare (solifenacin) plus behavioral modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT00821184?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.